Guest Editors
Professor Dr. Jafar Rezaie, Solid Tumor Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Iran. Rezaie.j@umsu.ac.ir
Summary
Extracellular vesicles (EVs) are phospholipid bilayer vesicles released from tumor and non-tumor cells for intercellular communication. EVs contain different types of proteins, nucleic acids, and lipids that contribute to affect target cell function and fate. Three main subclasses of EVs including exosomes, microvesicles, and apoptotic bodies have been categorized, which represent pivotal roles in cellular physiology. Exosomes, 30-150 nm EVs, have dramatically fascinated the attention of researchers owing to their pivotal roles in carcinogenesis and cancer treatment. Exosomes biogenesis may show a crosstalk with other signaling pathways such as autophagy, apoptosis, and P53/TSPA6 to preserve cellular hemostasis.
This Special Issue is dedicated to the roles of EVs in cancer progress and treatment, with specific highlighting on the role of exosomes as cell-to-cell communication mediators in cancer management.
Areas of interest include, but are not limited to:
• Exosomes signaling pathway in tumor cells.
• Tumor angiogenesis and exosomes/microvesicles.
• Tumor immunology and exosomes/microvesicles.
• Tumor resistance to therapies and exosomes.
• Exosomes as drug-delivery particles.
• Exosomes therapy for cancer.
• Exosomes and biomarkers for cancer.
• Crosstalk between exosomes, autophagy and apoptosis signalings
Keywords
Extracellular vesicles; Exosomes; Tumor environment; Drug-delivery; Biomarker; Exosomes-autophagy crosstalk
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue